Ravelcare IPO at a Glance

Ravelcare Limited is a fast‑growing personal care and hygiene brand that’s now stepping into public markets. The company focuses on affordable, aspirational products and is using the SME IPO route to fund aggressive marketing and capacity expansion.

Key IPO terms from the offer document and exchange disclosures:​

• IPO type: SME, book‑built
• Issue size: ~₹24.11 crore (fresh issue)
• Price: ₹130 per share (face value ₹10)
• IPO opening: 1 December 2025
• IPO closing: 3 December 2025
• Allotment: 4 December 2025
• Listing: 8 December 2025 (SME platform)
• Market lot: 2,000 shares
• Minimum retail application: 2,000 shares (₹2,60,000)

Investor reservation:-

• Anchor: 28.32% (5,25,000 shares)
• QIB (ex‑anchor): 18.93%
• NII: 14.24%
• Retail: 33.44%.​

Business & Financial Snapshot

Ravelcare operates in the beauty and personal care space, with a portfolio that includes skincare, haircare, and hygiene products positioned for mass‑premium consumers. The business is brand‑driven and supported by modern trade, e‑commerce and distributor networks.

Financial performance (₹ in crore):​

Ravelcare Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 5% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended	30 Sep 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	15.68	11.63	8.03	1.74
Total Income	14.44	25.30	22.28	3.49
Profit After Tax	3.20	5.26	5.02	0.41
EBITDA	4.33	6.82	6.64	0.51
NET Worth	13.55	10.35	5.10	0.07
Reserves and Surplus	8.54	5.35	5.09	0.07
Total Borrowing			0.04	0.41

 

IPO Lot Size :-

Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Key ratios FY25:​

• EBITDA margin: 27.30%
• PAT margin: 21.04%
• ROE: 68.04%
• ROCE: 68.32%
• Debt‑equity: Nil (debt‑free)
• EPS (basic): ₹16.44
• NAV: ₹20.68

These numbers tell the story of a young brand coming off a low base, but already delivering strong margins and return ratios.

Objective of the IPO:-

As per the RHP summary:​

• Brand‑building & advertising: ₹11.50 crore to strengthen visibility, digital campaigns, and offline presence.
• New manufacturing facility at Mauje‑Peth, Amravati (Maharashtra): ₹7.84 crore for capex on the proposed plant.
• General corporate purposes: Balance funds for working capital, talent, technology, and expansion needs.

How To Apply for the IPO ?

• Login or Open demat account with JM Financial Services / JM PRO app: Open the JM PRO app or JM Financial Services website and log in with your credentials. 
• Locate the IPO Section: Navigate to the 'IPO' section on the platform. 
• Select IPO: Find and select the IPO from the list of open IPOs. 
• Enter the Lot Size: Specify the number of lots you want to bid for. 
• Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application. 
• Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN. 

How To Check the Allotment Status of IPO?

Steps to check IPO allotment status on JM Pro app: 

• Log in to the JM Pro app. 
• Go to the IPO Section and then to IPO Orders. 
• Select the individual IPO that you had applied for and check the allotment status. 

JM Financial Services will notify you of your IPO allotment status via push notification and email

FAQs

Q1. What are the Ravelcare IPO dates and listing timeline?
A: The IPO runs from 1 December to 3 December 2025; allotment is on 4 December and listing is on 8 December 2025.​

Q2. What is the Ravelcare IPO price and lot size?
A: The issue price is ₹130 per share and the minimum lot is 2,000 shares (₹2,60,000 for retail investors).​

Q3. How is the IPO reserved among investors?
A: Anchor 28.32%, QIB (ex‑anchor) 18.93%, NII 14.24%, Retail 33.44% of the net offer.​

Q4. What will the IPO proceeds be used for?
A: Brand marketing, setting up a new manufacturing facility at Amravati, and general corporate purposes.

Q5. Is Ravelcare profitable and debt‑free?
A: Yes. FY25 PAT was ₹5.26 crore, PAT margin 21.04%, and the company reports no financial debt on its books.

Q6. Are there any listed peers?
A: The offer document notes no directly comparable listed companies in India in exactly the same niche.